Clinical trial
ACCElerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System
NCT02159521 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACCElerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 10, 2014
- Completion date
- November 30, 2017
- Enrollment
- 81 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, post-thrombotic syndrome